Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension-Reference-Cited by-同舟云学术

Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension

Published:2002-12 Issue:12 Volume:16 Page:819-827
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Zhang R,Thakur V,Morse S,Reisin E

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001496.pdf

Reference85 articles.

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL . Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys, 1960 to 1991 JAMA 1994 272: 205–211

2. Hubert HB, Feinleib M, McNamara PM, Castelli WP . Obesity as an independent risk factor for cardio-vascular disease: a 26-year follow-up of participants in the Framingham heart study Circulation 1983 72: 53–60

3. Kannel WB et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham Study Ann Intern Med 1967 67: 48–59

4. Stevens J et al. The effect of age on the association between body-mass index and mortality N Engl J Med 1997 338: 1–7

5. Kambham N et al. Obesity-related glomerulopathy: an emerging epidemic Kidney Int 2001 59: 1498–1509

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The “Weight” of Obesity on Arterial Hypertension;Understanding the Molecular Crosstalk in Biological Processes;2020-06-24

2. Transplantation: Kidney, Kidney–Pancreas Transplant;Diabetes and Kidney Disease;2014

3. Lifestyle modifications;Hypertension;2013-06

4. Transplantation in Obese Patient;Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine;2012-05

5. Hypertensive Treatment and the Metabolic Syndrome;Current Hypertension Reviews;2011-11-01